Predicting prostate cancer many years before diagnosis: how and why?

Evidence of reduced prostate cancer mortality from randomized trials in Europe supports early detection of prostate cancer with prostate-specific antigen (PSA). Yet PSA screening has generated considerable controversy: it is far from clear that the benefits outweigh risks, in terms of overdiagnosis...

詳細記述

書誌詳細
主要な著者: Vickers, A, Lilja, H
フォーマット: Journal article
言語:English
出版事項: 2012